NY A10268

Adds new subsection (c-1) to Insurance Law Section 3238 regarding denial of coverage for concurrent symptoms or side effects lacking pre-authorization.

Requires that denials of treatment rendered simultaneously with a pre-authorized health care service can only be upheld on appeal if the treatment is not a covered benefit, not medically necessary, experimental or investigational, or meets other specified conditions in subsection (a).

Prevents insurers from denying payment for concurrent symptom or side effect treatment when the primary service received pre-authorization, unless specific grounds for denial are established.

Takes effect 90 days after becoming law.